Weight Loss Recognizing its weight loss benefits, the FDA approved the brand name Wegovy for weight management in overweight or obese adults
Patients should seek urgent medical attention if they experience: Severe, persistent abdominal pain, especially if radiating to the back (possible pancreatitis) Persistent vomiting/diarrhoea with reduced urine output (dehydration/acute kidney injury) Jaundice or right upper quadrant pain (possible gallbladder disease) Signs of severe allergic reaction (facial swelling, breathing difficulty, rash) New or worsening visual symptoms (for people with diabetes) Suspected side effects should be reported via the MHRA Yellow Card scheme (yellowcard
Not FDA approved for human or veterinary use.
Jeff Giullian, chief medical officer for DaVita, said at the time, adding, Based on the inclusion criteria for study participants, we believe there may be limited application of the FLOW study findings to the overall CKD patient population. He argued that the inclusion requirements necessary to partake in the FLOW trial, such as needing to be on a standard kidney disease treatment and have a certain amount of protein in the urine, were attributable to a narrow subset less than 10% of all current CKD patients
Women should also understand the commitment required, including regular follow-up appointments, potential side effects, and the importance of lifestyle modifications including nutrition and physical activity